A Study in Healthy Volunteers to Assess Safety and Blood Levels of AZD5847 After Multiple Doses Over 14 Days

Completed · Phase 1 · Has a placebo group

Conditions studied: Healthy

In brief

The purpose of this study is to determine the safety, tolerability and blood levels of AZD5847 after daily oral dosing for 14 days.

Key facts

Study ID

NCT01116258

Run by

AstraZeneca

People needed

60

Starts

2010-04-01

Expected to finish

2010-10-01

Last updated by the study team

2010-10-11

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• BMI between 18-30

You may not qualify if…

• Use of drugs that inhibit or induce cytochrome P450 3A4 enzymes
• History of presence of gastrointestinal, hepatic or renal disease

Where it is running

• Research Site — Overland Park, Kansas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.